1. Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete.
- Author
-
McArthur KA, Mitchell SS, Tsueng G, Rheingold A, White DJ, Grodberg J, Lam KS, and Potts BC
- Subjects
- Actinobacteria genetics, Anti-Bacterial Agents chemistry, California, Drug Resistance, Bacterial drug effects, Enterococcus faecium drug effects, Hydrocarbons, Chlorinated chemistry, Indoles chemistry, Marine Biology, Methicillin Resistance drug effects, Microbial Sensitivity Tests, Molecular Structure, Pyrroles chemistry, Staphylococcus aureus drug effects, Vancomycin Resistance drug effects, Actinobacteria chemistry, Anti-Bacterial Agents isolation & purification, Anti-Bacterial Agents pharmacology, Gram-Negative Bacteria drug effects, Gram-Positive Bacteria drug effects, Hydrocarbons, Chlorinated isolation & purification, Hydrocarbons, Chlorinated pharmacology, Indoles isolation & purification, Indoles pharmacology, Pyrroles isolation & purification, Pyrroles pharmacology
- Abstract
A series of chlorinated bisindole pyrroles, lynamicins A-E (1-5), was discovered from a novel marine actinomycete, NPS12745, which was isolated from a marine sediment collected off the coast of San Diego, California. Close to full length 16S rRNA sequence analysis indicated that NPS12745 is a novel strain of a recently described marine actinomycete with the proposed genus name Marinispora. The antimicrobial spectrum of these compounds was evaluated against a panel of 11 pathogens, which demonstrated that these substances possess broad-spectrum activity against both Gram-positive and Gram-negative organisms. Significantly, compounds 1-5 were active against drug-resistant pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
- Published
- 2008
- Full Text
- View/download PDF